- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05407935
Early Phase Clinical Trial to Test the Feasibility of an ACT-based Physical Activity Promotion Program for Adults With Depressive Symptoms
July 18, 2022 updated by: David M. Williams, Brown University
The goal of the proposed project is to conduct a feasibility clinical trial comparing group-based acceptance and commitment therapy for physical activity, (ACT; ACTivity) to a time- and attention-matched standard PA intervention (i.e., PA education, goal-setting, and self-monitoring) plus relaxation training comparison condition (Relaxercise) among 60 low-active adults (ages 18-65) with elevated depressive symptoms.
Participants will be randomized to treatment condition, followed for 6 months, including the 8-week treatment.
Participants will be randomized 1:1 to treatment condition, followed for 6 months, including the 8-week treatment, and receive a 6-month YMCA membership to equate access to PA facilities.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lauren C Bohlen, Ph.D.
- Phone Number: 401-863-6559
- Email: lauren_bohlen@brown.edu
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02912
- Recruiting
- Brown University
-
Contact:
- Lauren Connell Bohlen, PhD
- Phone Number: 401-863-6559
- Email: lauren_bohlen@brown.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Elevated depressive symptoms (CES-D score of greater than or equal to 10)
- Low-active (less than 60 minutes per week of moderate intensity PA)
- Willing and able to attend weekly virtual video sessions via Zoom
Exclusion Criteria:
- Regular mindfulness meditation practice (more than once per week)
- Body Mass Index (BMI) less than 18.5 or greater than 40
- History or presence of any condition that may limit or substantially increase the risks of physical activity
- Active suicidal thoughts or behaviors
- Currently participating in any exercise or weight-loss research studies
- Household member is participating in this study
- Does not have a Rhode Island mailing address OR if only Rhode Island mailing address is a PO box
- Unable to receive materials in the mail at residential mailing address
- Does not plan to live in Rhode Island for the next 6 months
- Unable to speak, read, and/or write fluently in English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ACTivity
Acceptance and Commitment Therapy for physical activity promotion plus standard physical activity promotion strategies (i.e., goal-setting, self-monitoring)
|
Acceptance and Commitment Therapy for physical activity promotion plus standard physical activity promotion strategies (i.e., goal-setting, self-monitoring)
|
Active Comparator: Relaxercise
Relaxation training plus standard physical activity promotion strategies (i.e., goal-setting, self-monitoring)
|
Relaxation training plus standard physical activity promotion strategies (i.e., goal-setting, self-monitoring)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Accelerometry
Time Frame: Baseline, Post-Treatment (8 weeks), 6-months
|
Minutes of physical activity weighted by intensity, expressed in metabolic equivalent (MET) minutes per week as determined by accelerometers (Actigraph [model wGT3x-BT]) worn during one-week periods.
|
Baseline, Post-Treatment (8 weeks), 6-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Self-report physical activity (Godin)
Time Frame: Baseline, Mid-Treatment (4 weeks) Post-Treatment (8 weeks), 6-months
|
Self-reported minutes of leisure time physical activity per week weighted by intensity
|
Baseline, Mid-Treatment (4 weeks) Post-Treatment (8 weeks), 6-months
|
Change in Self-reported depression symptoms (CES-D)
Time Frame: Baseline, Mid-Treatment (4 weeks) Post-Treatment (8 weeks), 6-months
|
Score on the Center for Epidemiological Studies Depression Scale (CES-D)
|
Baseline, Mid-Treatment (4 weeks) Post-Treatment (8 weeks), 6-months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Physical activity values clarification (valuing questionnaire)
Time Frame: Baseline, Mid-Treatment (4 weeks) Post-Treatment (8 weeks), 6-months
|
Measures how a person's values align with physical activity
|
Baseline, Mid-Treatment (4 weeks) Post-Treatment (8 weeks), 6-months
|
Change in Acceptance of physical activity-related distress (Physical Activity Acceptance Questionnaire)
Time Frame: Baseline, Mid-Treatment (4 weeks) Post-Treatment (8 weeks), 6-months
|
Measures the extent to which a person can tolerate any distress associated with physical activity
|
Baseline, Mid-Treatment (4 weeks) Post-Treatment (8 weeks), 6-months
|
Change in Physical activity-related motivation (Treatment Self-Regulation Questionnaire - Exercise Version)
Time Frame: Baseline, Mid-Treatment (4 weeks) Post-Treatment (8 weeks), 6-months
|
Measures the extent to which a person is motivated to engage in physical activity
|
Baseline, Mid-Treatment (4 weeks) Post-Treatment (8 weeks), 6-months
|
Change in Discomfort intolerance (Discomfort Intolerance Scale)
Time Frame: Baseline, Mid-Treatment (4 weeks) Post-Treatment (8 weeks), 6-months
|
Measures the extent to which a person can tolerate uncomfortable experiences
|
Baseline, Mid-Treatment (4 weeks) Post-Treatment (8 weeks), 6-months
|
Change in Physical activity enjoyment (PACES questionnaire)
Time Frame: Baseline, Mid-Treatment (4 weeks) Post-Treatment (8 weeks), 6-months
|
Measures the extent to which a person enjoys physical activity
|
Baseline, Mid-Treatment (4 weeks) Post-Treatment (8 weeks), 6-months
|
Change in Credibility and expectancy questionnaire
Time Frame: Week 1 (After the first treatment session)
|
Measures perceived credibility and expected benefits of treatment
|
Week 1 (After the first treatment session)
|
Change in Client satisfaction questionnaire
Time Frame: Post-Treatment (8 weeks) and following the booster session (12 weeks)
|
Measures satisfaction with treatment
|
Post-Treatment (8 weeks) and following the booster session (12 weeks)
|
Change in Group cohesion questionnaire
Time Frame: Post-Treatment (8 weeks)
|
Measures perceived cohesiveness of the treatment group
|
Post-Treatment (8 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Da M Wil, Ph.D., Brown University School of Public Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 7, 2022
Primary Completion (Anticipated)
May 31, 2023
Study Completion (Anticipated)
August 31, 2023
Study Registration Dates
First Submitted
May 31, 2022
First Submitted That Met QC Criteria
June 3, 2022
First Posted (Actual)
June 7, 2022
Study Record Updates
Last Update Posted (Actual)
July 20, 2022
Last Update Submitted That Met QC Criteria
July 18, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R34AT011302 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physical Inactivity
-
University of Alabama at BirminghamRecruitingDisability Physical | Physical InactivityUnited States
-
University of IowaNational Institute on Aging (NIA); Northeastern UniversityNot yet recruiting
-
Ludwig Boltzmann Institute for Digital Health and...RecruitingPhysical InactivityAustria
-
University of MichiganNational Institute on Aging (NIA)Recruiting
-
University of MinnesotaRecruitingPhysical InactivityUnited States
-
Brown UniversityNational Cancer Institute (NCI)Recruiting
-
Universiti Putra MalaysiaRecruitingInactivity, PhysicalPakistan
-
University of Milano BicoccaFederico II University; University of BergamoRecruitingPhysical InactivityItaly
-
University of CalgaryPublic Health Agency of Canada (PHAC)Recruiting
-
Brown UniversityNational Institute of General Medical Sciences (NIGMS)CompletedPhysical InactivityUnited States
Clinical Trials on ACTivity
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant Bone NeoplasmUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Recruiting
-
Weill Medical College of Cornell UniversityWeill Cornell Medical College in QatarWithdrawn
-
ElsanNot yet recruitingIndividualised Physical Activity Program | Coronary Patient
-
University of California, San DiegoRecruitingCognitive Change | Aging | Mild Cognitive Impairment | Cognitive Decline | Memory Disorders | Memory Impairment | Cognition Disorders in Old Age | Aging Problems | Memory Loss | Memory Disorders in Old Age | Memory Disorder, SpatialUnited States
-
Health Education Research Foundation (HERF)CompletedQuality of LifePakistan
-
Mclean HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingBinge-Eating DisorderUnited States
-
University of ThessalyCompleted
-
Zohra Institute of Health SciencesCompletedPhysical Activity and StressPakistan
-
Centre Leon BerardNational Cancer Institute, FranceNot yet recruitingMetastatic Testicular CancerFrance